» Articles » PMID: 15102715

Brefeldin A and Filipin Distinguish Two Globotriaosyl Ceramide/verotoxin-1 Intracellular Trafficking Pathways Involved in Vero Cell Cytotoxicity

Overview
Journal Glycobiology
Date 2004 Apr 23
PMID 15102715
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In verotoxin 1 (VT1)-sensitive cells, globotriaosyl ceramide (Gb3) bound VT1 is endocytosed and transported retrogradely to the Golgi/endoplasmic reticulum (ER). The importance of the Golgi-dependent retrograde transport of VT1 is now shown to vary as a function of both VT1 exposure time and concentration. Following 3 h exposure to < 50 ng/ml VT1, Vero cell cytotoxicity and protein synthesis inhibition is absolutely dependent on intact Golgi structure. However, after 24 h incubation with concentrations of VT1 above 50 ng/ml, a filipin-sensitive (caveolae-dependent) route for cytotoxicity becomes significant. Brefeldin A (BFA), which prevents Golgi-dependent retrograde traffic, protects cells from low VT1 concentrations but not following prolonged toxin exposure at higher VT1 concentrations. Under these conditions, only a combination of BFA and filipin is sufficient to fully protect cells. Intracellular VT1 trafficking monitored using the nontoxic B subunit showed accumulation within BFA-collapsed TGN/endosomes. Considerable VT1 B was retained at the surface of filipin-treated cells, but Golgi targeting was still apparent. Filipin-sensitive VT1 cytotoxicity does not require Golgi access and may involve direct transmembrane signaling. Although cell surface VT1 does not colocalize with caveolin 1, a small fraction of endocytosed VT1 is found within caveolin 1-containing vesicles. These studies indicate both a caveolae-dependent and independent pathway for VT1 access to the TGN/Golgi from the cell surface and two noninterconverting pools of membrane Gb3.

Citing Articles

Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury and lethality in host.

Lee K, Lee J, Lee P, Jeon B, Song M, Kwak S EMBO Mol Med. 2021; 14(1):e14678.

PMID: 34842355 PMC: 8749473. DOI: 10.15252/emmm.202114678.


Verotoxin Receptor-Based Pathology and Therapies.

Lingwood C Front Cell Infect Microbiol. 2020; 10:123.

PMID: 32296648 PMC: 7136409. DOI: 10.3389/fcimb.2020.00123.


Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases.

Adnan H, Zhang Z, Park H, Tailor C, Che C, Kamani M PLoS One. 2016; 11(12):e0166948.

PMID: 27935997 PMC: 5147855. DOI: 10.1371/journal.pone.0166948.


Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.

Steil D, Schepers C, Pohlentz G, Legros N, Runde J, Humpf H J Lipid Res. 2015; 56(12):2322-36.

PMID: 26464281 PMC: 4655988. DOI: 10.1194/jlr.M063040.


Binding profiles and cytokine-inducing effects of fish rhamnose-binding lectins on Burkitt's lymphoma Raji cells.

Hosono M, Sugawara S, Matsuda A, Tatsuta T, Koide Y, Hasan I Fish Physiol Biochem. 2014; 40(5):1559-72.

PMID: 24861899 DOI: 10.1007/s10695-014-9948-1.